Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
Despite the continued development of cystic fibrosis transmembrane conductance regulator (CFTR) modulator drugs for the treatment of cystic fibrosis (CF), the need for mutation agnostic treatments remains. In a sub-group of CF individuals with mutations that may not respond to modulators, such as th...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-03-01
|
| Series: | Genes |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2073-4425/10/3/218 |